Showing results (31-40 of 436) with videos related to
Sort By:
Pageof 44
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Not all monoclonals are created equal - lessons from failed drug trials in Crohn's diseaseArthur KaserScandinavian Journal of Gastroenterology|July 9, 2008
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver diseaseOthmar Ludwiczek, Edouard Vannier, Alexander Moschen, et al.Wiener Medizinische Wochenschrift (1946)|July 12, 2013
[Management of severe alcoholic hepatitis]Verena Wieser, Herbert TilgAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|July 9, 2005
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liverGernot Zollner, Martin Wagner, Peter Fickert, et al.Metabolism: Clinical and Experimental|February 25, 2016
Nonalcoholic fatty liver disease and hepatocellular carcinomaHeinz Zoller, Herbert TilgCurrent Opinion in Clinical Nutrition and Metabolic Care|May 18, 2010
Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammationHerbert Tilg, Alexander MoschenEuropean Journal of Gastroenterology & Hepatology|November 20, 2002
Splanchnic blood flow determination in patients with suspected chronic intestinal ischaemiaHerbert Tilg, Hannes GaenzerAnnual Review of Medicine|October 31, 2025
Potential Health Risks of Artificial SweetenersMaria Effenberger, Herbert TilgClinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.European Cytokine Network|January 4, 2005
Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonistClemens Molnar, Elena R Garcia-Trevijano, Othmar Ludwiczek, et al.Pageof 44